The Potential and Advantages of Using the AS01 Adjuvant in Next-Generation Adjuvanted Influenza Vaccines
Influenza vaccines represent one of the largest segments of the global vaccine market (with the global market size exceeding $8 billion by 2025). However, the protective efficacy of traditional split-virus vaccines has long hovered between 30% and 50% among individuals aged 65 and older and immunocompromised populations. Additionally, these vaccines require annual updates, offer short-term...
0 发布评论计数 0 分享 4 查看 0 評論